More employers are dropping the largest PBMs

Recent coverage from Managed Healthcare Executive, PR Newswire, MedCity News, Bloomberg Law News, and Axios details a notable shift among employers moving away from the largest pharmacy benefit managers, frequently referred to as the big three PBMs. According to survey data from the National Alliance, employer utilization of these dominant PBM entities has declined in 2026. This trend highlights a growing discontent with existing prescription drug administration structures, prompting organizations to seek out alternative providers for their healthcare and pharmacy benefit needs. Media outlets including Axios and MedCity News emphasize that this movement away from industry heavyweights signals an impending transformation in market dynamics.

Bloomberg Law News and PR Newswire further report on critical assessments regarding the pharmacy system, noting commentary that the current reward structure generates incorrect outcomes while functioning precisely as originally designed. Coverage consistently points to the National Alliance survey as the primary empirical source documenting this retreat from major PBM contractors. The broader context provided by the reporting indicates persistent dissatisfaction among corporate benefit purchasers regarding how prescription drug benefits are managed and financed. Historically, the largest PBMs have held dominant market share, controlling drug formularies and pricing negotiations.

The current reporting highlights that this longstanding dominance is facing tangible pushback as employers actively evaluate alternative PBM models in an effort to secure more favorable outcomes for their organizations and plan members. Looking ahead, coverage does not yet specify the exact identities of the alternative PBMs gaining employer business or the specific financial terms of these newly established contracts. Observers will need to monitor further reporting from the National Alliance and related outlets to determine the long-term impact of this market shift on the broader healthcare and pharmacy benefit management industry as these new dynamics continue to unfold across the corporate landscape.